Shire submits lifitegrast Marketing Authorization Application for treatment of dry eye disease in Europe Read more
Jounce Therapeutics Names Hugh Cole as Chief Business Officer and Head of Corporate Development Read more
PharmaMar Starts a Quadruple Combination Study With Aplidin for the Treatment of Multiple Myeloma Read more